NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Equities Make Strong Comeback on Thursday

Indian equities staged a strong comeback in Thursday's trade, May 14, with the benchmark indices settling over 1% higher. The rally was led by strong buying in pharma and metal stocks, which brought much-needed optimism back to Dalal Street.

The Indian rupee, however, slipped to another record low of 95.9 against the US dollar during the session. Despite this, both the Nifty 50 and the Sensex ended the session with gains of over 1%. The broader market, however, closed on a mixed note, with the Nifty Midcap 100 index surging 1.10%, while the Nifty Smallcap 100 index ended marginally lower with a 0.08% decline.

SectorIndex Performance (%)
Nifty Pharma2.73
Nifty Metal2.00
Nifty PSU Bank1.20
Nifty Chemicals1.15
Nifty Consumer Durables1.10
Nifty IT-1.90

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Among sectors, the Nifty Pharma index emerged as the top performer, surging 2.73%, while the Nifty Metal index gained 2%. Other sectors, including Nifty PSU Bank, Nifty Chemicals, and Nifty Consumer Durables, also advanced over 1%. On the flip side, Nifty IT was the sole laggard, declining nearly 2%.

Meanwhile, geopolitical tensions remain elevated as prospects of a peace deal in West Asia weakened after US President Donald Trump termed Iran's conditions as unacceptable. Investors are also closely monitoring the upcoming meeting between Trump and Chinese President Xi Jinping for further cues on global trade and economic policy.

Investor Takeaway

Investors should focus on pharma and metal stocks for potential gains.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.